Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18275516rdf:typepubmed:Citationlld:pubmed
pubmed-article:18275516lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:18275516lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:18275516lifeskim:mentionsumls-concept:C0004057lld:lifeskim
pubmed-article:18275516lifeskim:mentionsumls-concept:C0162595lld:lifeskim
pubmed-article:18275516lifeskim:mentionsumls-concept:C2921106lld:lifeskim
pubmed-article:18275516lifeskim:mentionsumls-concept:C1446409lld:lifeskim
pubmed-article:18275516lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:18275516lifeskim:mentionsumls-concept:C0521114lld:lifeskim
pubmed-article:18275516lifeskim:mentionsumls-concept:C1514923lld:lifeskim
pubmed-article:18275516pubmed:issue3lld:pubmed
pubmed-article:18275516pubmed:dateCreated2008-2-15lld:pubmed
pubmed-article:18275516pubmed:abstractTextIt is well known that treatment with aspirin plus heparin is effective for patients with antiphospholipid syndrome (APS) to prevent pregnancy loss. However, it is unclear if occasional antiphospholipid antibodies (aPL) are a risk factor and whether patients with aPL at one time point but not diagnosed as APS should be treated.lld:pubmed
pubmed-article:18275516pubmed:languageenglld:pubmed
pubmed-article:18275516pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18275516pubmed:citationSubsetIMlld:pubmed
pubmed-article:18275516pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18275516pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18275516pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18275516pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18275516pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18275516pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18275516pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18275516pubmed:statusMEDLINElld:pubmed
pubmed-article:18275516pubmed:monthMarlld:pubmed
pubmed-article:18275516pubmed:issn1046-7408lld:pubmed
pubmed-article:18275516pubmed:authorpubmed-author:SatoTakeshiTlld:pubmed
pubmed-article:18275516pubmed:authorpubmed-author:SuzumoriNobuh...lld:pubmed
pubmed-article:18275516pubmed:authorpubmed-author:Sugiura-Ogasa...lld:pubmed
pubmed-article:18275516pubmed:authorpubmed-author:OzakiYasuhiko...lld:pubmed
pubmed-article:18275516pubmed:authorpubmed-author:NakanishiTama...lld:pubmed
pubmed-article:18275516pubmed:authorpubmed-author:KumagaiKyokoKlld:pubmed
pubmed-article:18275516pubmed:issnTypePrintlld:pubmed
pubmed-article:18275516pubmed:volume59lld:pubmed
pubmed-article:18275516pubmed:ownerNLMlld:pubmed
pubmed-article:18275516pubmed:authorsCompleteYlld:pubmed
pubmed-article:18275516pubmed:pagination235-41lld:pubmed
pubmed-article:18275516pubmed:meshHeadingpubmed-meshheading:18275516...lld:pubmed
pubmed-article:18275516pubmed:meshHeadingpubmed-meshheading:18275516...lld:pubmed
pubmed-article:18275516pubmed:meshHeadingpubmed-meshheading:18275516...lld:pubmed
pubmed-article:18275516pubmed:meshHeadingpubmed-meshheading:18275516...lld:pubmed
pubmed-article:18275516pubmed:meshHeadingpubmed-meshheading:18275516...lld:pubmed
pubmed-article:18275516pubmed:meshHeadingpubmed-meshheading:18275516...lld:pubmed
pubmed-article:18275516pubmed:meshHeadingpubmed-meshheading:18275516...lld:pubmed
pubmed-article:18275516pubmed:meshHeadingpubmed-meshheading:18275516...lld:pubmed
pubmed-article:18275516pubmed:meshHeadingpubmed-meshheading:18275516...lld:pubmed
pubmed-article:18275516pubmed:meshHeadingpubmed-meshheading:18275516...lld:pubmed
pubmed-article:18275516pubmed:meshHeadingpubmed-meshheading:18275516...lld:pubmed
pubmed-article:18275516pubmed:meshHeadingpubmed-meshheading:18275516...lld:pubmed
pubmed-article:18275516pubmed:meshHeadingpubmed-meshheading:18275516...lld:pubmed
pubmed-article:18275516pubmed:meshHeadingpubmed-meshheading:18275516...lld:pubmed
pubmed-article:18275516pubmed:meshHeadingpubmed-meshheading:18275516...lld:pubmed
pubmed-article:18275516pubmed:meshHeadingpubmed-meshheading:18275516...lld:pubmed
pubmed-article:18275516pubmed:meshHeadingpubmed-meshheading:18275516...lld:pubmed
pubmed-article:18275516pubmed:meshHeadingpubmed-meshheading:18275516...lld:pubmed
pubmed-article:18275516pubmed:year2008lld:pubmed
pubmed-article:18275516pubmed:articleTitleOccasional antiphospholipid antibody positive patients with recurrent pregnancy loss also merit aspirin therapy: a retrospective cohort-control study.lld:pubmed
pubmed-article:18275516pubmed:affiliationDepartment of Obstetrics and Gynecology, Nagoya City University Medical School, Mizuho-ku, Nagoya, Aichi, Japan. og.mym@med.nagoya-cu.ac.jplld:pubmed
pubmed-article:18275516pubmed:publicationTypeJournal Articlelld:pubmed